Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 5.57 +0.03 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.54 | 52 Week High | $45.34 | |||
| Open | $5.60 | 52 Week Low | $15.92 | |||
| Day High | $5.74 | P/E | 2.39 | |||
| Day Low | $5.45 | EPS | $2.33 | |||
| Volume | 4,951,510 | |||||
| (NASDAQ: SOPH) | Delayed: 7.35 +0.42 (6.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.93 | 52 Week High | $ | |||
| Open | $6.99 | 52 Week Low | $ | |||
| Day High | $7.43 | P/E | N/A | |||
| Day Low | $6.98 | EPS | $ | |||
| Volume | 591,930 | |||||
